Effect of Nicotine-Induced Corticosterone Elevation on Nitric Oxide Production in the Passive Skin Arthus Reaction in Rats

Journal of Pharmacological Sciences

Volumn 94, Issue 1, 2004, Pages 31-38

  Kubo, Kaoru ^a   Kita, Taizo ^b   Tsujimura, Takahiro ^a   Nakashima, Toshikatsu ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b Daiich Coll of Pharmaceut Sciences   (Japan)

Author keywords

Nicotine; Nitric oxide; Passive skin Arthus reaction; Superoxide; Tumor necrosis factor

Indexed keywords

ARGININE; CORTICOSTERONE; GLUCOCORTICOID; MIFEPRISTONE; MYELOPEROXIDASE; N(G) NITROARGININE METHYL ESTER; NICOTINE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHUS PHENOMENON; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG ACTIVITY; DRUG MECHANISM; EXUDATE; INFLAMMATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; RAT; SKIN MANIFESTATION;

EID: 1042302849     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.94.31     Document Type: Article

References (45)

1. Chrousos GP. The hypothalamic-pituitary-adrenal axis and imune-mediated inflammation. N Engl J Med. 1995;332:1351-1362.
2. Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 1984;5:25-44.
3. Morand EF, Leech M. Glucocorticoid regulation of inflammation: the plot thickens. Inflamm Res. 1999;48:557-560.
4. Leech M, Santos LL, Metz C, Holdsworth SR, Bucala R, Morand EF. Control of macrophage migration inhibitory factor (MIF) by endogenous glucocorticoids in rat adjuvant arthritis. Arthritis Rheum. 2000;43:827-833.
5. Saphier D, Ovadian H. Selective facilitation of putative corticotropin-releasing factor-secreting neurones by interleukin-1. Neurosci Lett. 1990;114:283-288.
6. Hayley S, Wall P, Anisman H. Sensitization to the neuroendocrine, central monoamine and behavioural effects of murine tumor necrosis factor-alpha: peripheral and central mechanisma. Eur J Neurosci. 2002;15:1061-1076.
7. Vallieres L, Rivest S. Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemis. Endocrinology. 1999;140:3890-3893.
8. Andersson K, Siegel R, Fuxe K, Eneroth P. Intravenous injections of nicotine induce very rapid and discrete reductions of hypothalamic catecholamine levels associated with increases of ACTH, vasopressin and prolactin secretion. Acta Physiol Scand. 1983;118:35-40.
9. Cam GR, Bassett JR, Cairncross KD. The action of nicotine on the pituitary-adrenal cortical axis. Arch Int Pharmacodyn. 1979;237:49-66.
10. Matta SG, Beyer HS, McAllen KM, Sharp BM. Nicotine elevates rat plasma ACTH by a central mechanism. J Pharmacol Exp Therap. 1987;243:217-226.
11. Okuda H, Shioda S, Nakai Y, Nakayama H, Okamoto M, Nakashima T. Immunocytochemical localization of nicotinic acetylcholine receptor in rat hypothalamus. Brain Res. 1993;625:145-151.
12. Miao FJP, Benowitz NL, Basbaum AI, Levine JD. Sympathoadrenal contribution to nicotine and muscarinic modulation of bradykinin-induced plasma extravasation in the knee joint of the rat. J Pharmacol Exp Ther. 1992;262:889-895.
13. Miao FJP, Benowitz NL, Heller PH, Levine JD. Contribution of adrenal hormones to nicotine-induced inhibition of synovial plasma extravasation in the rat. Br J Pharmacol. 1997;120:298-304.
14. Kubo K, Kita T, Narushima I, Tanaka T, Nakatani T, Nakashima T. Nicotine- induced inflammatory decreasing effect on the passive skin Arthus reaction in paraventricular nucleus-lesioned wistar rats. Pharmacol Toxicol. 2003;92:125-130.
15. Kuriyama K, Hiyama Y, Ito K, Ichikawa K, Kitada S, Yoshinaka I. The pharmacological properties of a new anti-allergic agent, KP-136, in cutaneous models. Nippon Yakurigaku Zasshi (Folia Pharmacol Jpn). 1987;89:213-224. (text in Japanese with English abstract)
16. Kuriyama K, Fujiwara A, Inagaki K, Abe Y. Anti-inflammatory action of a novel peptide, SEK-1005, isolated from a Streptomyces. Eur J Pharmacol. 2000;390:223-228.
17. Peeters BW, van Rijn CM, Vossen JM, Coenen AM. Involvement of glucocorticoids in the acquired immobility response is dependent on the water temperature. Physiol Behav. 1992;51:127-129.
18. Harada M, Takeuchi M, Fukao T, Katagiri K. A simple method for the quantitative extraction of dye extravasated into the skin. J Pharm Pharmacol. 1971;23:218-219.
19. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206-209.
20. McCall TB, Palmer RMJ, Moncada S. Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur J Immunol. 1991;21:2523-2527.
21. Rodenas J, Carbonell T, Mitjavila T. Conditions to study nitric oxide generation by polymorphonuclear cells from an inflammatory excudate in rats. Arch Biochem Biophys. 1996;327:292-294.
22. Huber W, Saifer MPG. Orgotein, the drug version of bovine Cu-Zn superoxide dismutase. Superoxide and Superoxide Dismutases. In: Michelson AM, McCord JM, Fridovich I, editors. London: Academic Press; 1977. p. 517-536.
23. McCormick JR, Harkin MM, Johnson KJ, Ward PA. Suppression by superoxide dismutase of immune-complex-induced pulmonary alveolitis and dermal inflammation. Am J Pathol. 1981;102:55-61.
24. - in neutrophil recruitment into sites of dermal and pulmonary vasculitis. Free Radical Biol Med. 1990;8:163-172.
25. Fujii E, Yoshioka T, Ishida H, Irie K, Muraki T. Evaluation of iNOS-dependent and independent mechanisms of the microvascular permeability change induced by lipopolysaccharide. Br J Pharmacol. 2000;130:90-94.
26. Handy RL, Moore PK. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity. Br J Pharmacol. 1998;123:1119-1126.
27. Weissmann G, Smolen JE, Hoffstein S. Polymorphonuclear leukocytes as secretory organs of inflammation. J Invest Dermatol. 1978;71:95-99.
28. Warren JS. Disparate roles for TNF in the pathogenesis of acute immune complex alveolitis and dermal vasculitis. Clin Immunol Immunopathol. 1991;61:249-259.
29. Flower RJ, Blackwell GJ. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature. 1979;278:456-459.
30. Lewis GP, Piper PJ. Inhibition of release of prostaglandins as an explanation of some of the actions of anti-inflammatory corticosteroids. Nature. 1975;254:308-311.
31. Camuccio R, DiRosa M, Guerrasio B, Iuvone T, Sautebin L. Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein. Br J Pharmacol. 1987;90:443-445.
32. Oyanagi Y, Suzuki S. Vasoregulin: a glucocorticoid-inducible vascular permeability inhibitory protein. Agents Actions. 1985;17:270-277.
33. Niwa M, Kozawa O, Mastuno H, Kanamori Y, Hara A, Uematsu T. Tumor necrosis factor-α-mediated signal transduction in human neutrophils: involvement of sphingomyelin metabolites in the priming effect of TNF-α on the FMLP-stimulated superoxide production, Life Sci. 2000;66:245-256.
34. Costantino G, Cuzzocrea S, Mazzon E, Caputi AP. Protective effets of melatonin in zymosan-activated plasma-induced paw inflammation. Eur J Pharmacol. 1998;363:57-63.
35. Greenacre SAB, Rocha FAC, Rawlingson A, et al. Protein nitration in cutaneous inflammation in the rat: essential role of inducible nitric oxide synthase and polymorohonuclear leukoytes. Br J Pharmacol. 2002;136:985-994.
36. Ridger VC, Greenacre SAB, Handy RLC, et al. Effect of peroxynitrite on the plasma extravasation, microvascular blood flow and nociception in the rat. Br J Pharmacol. 1997;122:1083-1088.
37. Mulligan MS, Hevel JM, Marletta MA, Ward PA. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci USA. 1991;88:6338-6342.
38. Sethi S, Sharma P, Dikshit M. Nitric oxide- and oxygen-derived free radical generation from control and lipopolysaccharide-treated rat polymorphonuclear leukocyte. Nitric Oxide. 2001;5:482-493.
39. Yang YH, Hutchinson P, Santos LL, Morand EF. Glucocorticoid inhibition of adjuvant arthritis synovial macrophage nitric oxide production: role of lipocortin 1. Clin Exp Immunol. 1998;111:117-122.
40. Fernandez BR, Crisci CD, Fiorenza G, Bertoya N. Evaluation of circulationg immune complexes in cutaneous disease associated with immune disorders. Allergol Immunopathol. 1990;18:47-52.
41. Fujii I, Shingu M, Nobunaga M. Monocyte activation in early rheumatoid arthritis. Ann Rheum Dis. 1990;49:496-503.
42. Madaio MP. The role of autoantibodies in the pathogenesis of lupus nephritis. Semin Nephrol. 1999;19:48-56.
43. Nabozny GH, David CS. The immunogenetic basis of collagen-induced arthritis in mice: an experimental model for the rational design of immunomodulatory treatments of rheumatoid arthritis. Adv Exp Med Biol. 1994;347:55-63.
44. Nahm DH, Park HS. C3-containing IgE immune complexes in asthmatic patients. J Korean Med Sci. 1996;11:217-221.
45. Zeuner M, Staub RH, Rauh G, Albert ED, Scholmerich J, Lang B. Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. J Rheumatol. 1996;24:96-101.